STOCK TITAN

Savara (SVRA) CFO exercises stock options and ends with 536,032 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Savara Inc Chief Financial Officer David L. Lowrance exercised several stock option grants on March 18, 2026, acquiring a total of 366,747 shares of Common Stock through option exercises at strike prices ranging from $1.11 to $4.45 per share. To cover exercise costs and tax obligations, 116,760 shares of Common Stock were withheld by the issuer in transactions coded as F, which are tax-withholding dispositions rather than open‑market sales. Following these transactions, Lowrance directly owned 536,032 shares of Savara common stock. The derivative transactions reflect routine option exercises tied to grants that vest in quarterly installments, as described in the footnotes.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lowrance David L

(Last)(First)(Middle)
1717 LANGHORNE NEWTOWN ROAD
SUITE 300

(Street)
LANGHORNE PENNSYLVANIA 19047

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Savara Inc [ SVRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/18/202603/18/2026M80,684A$1.51366,729D
Common Stock03/18/202603/18/2026F24,174D$5.04342,555D
Common Stock03/18/202603/18/2026M75,000A$1.59417,555D
Common Stock03/18/202603/18/2026F23,661D$5.04393,894D
Common Stock03/18/202603/18/2026M130,650A$1.23524,544D
Common Stock03/18/202603/18/2026F31,885D$5.04492,659D
Common Stock03/18/202603/18/2026M43,063A$1.11535,722D
Common Stock03/18/202603/18/2026F9,485D$5.04526,237D
Common Stock03/18/202603/18/2026M12,500A$4.45538,737D
Common Stock03/18/202603/18/2026F11,037D$5.04527,700D
Common Stock03/18/202603/18/2026M24,850A$3.35552,550D
Common Stock03/18/202603/18/2026F16,518D$5.04536,032D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$1.5103/18/202603/18/2026M80,684 (1)11/01/2026Common Stock80,684$0.000D
Stock Option (Right to Buy)$1.5903/18/202603/18/2026M75,000 (2)12/20/2029Common Stock150,000$0.0075,000D
Stock Option (Right to Buy)$1.2303/18/202603/18/2026M130,650 (3)12/16/2030Common Stock260,000$0.00129,350D
Stock Option (Right to Buy)$1.1103/18/202603/18/2026M43,063 (4)12/14/2031Common Stock100,000$0.0056,937D
Stock Option (Right to Buy)$4.4503/18/202603/18/2026M12,500 (5)12/14/2033Common Stock40,000$0.0027,500D
Stock Option (Right to Buy)$3.3503/18/202603/18/2026M24,850 (6)12/12/2034Common Stock300,000$0.00275,150D
Explanation of Responses:
1. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of November 1, 2016, subject to the reporting person's continued service with the Issuer.
2. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer.
3. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 16, 2020, subject to the reporting person's continued service with the Issuer.
4. The option vested and became exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2021, subject to the reporting person's continued service with the Issuer.
5. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 14, 2023, subject to the reporting person's continued service with the Issuer.
6. The option vests and becomes exercisable in sixteen equal installments on each quarterly anniversary of December 12, 2024, subject to the reporting person's continued service with the Issuer.
Remarks:
The option exercises reported herein were exercises of incentive stock options effected for tax planning purposes.
/s/ David Lowrance03/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Savara (SVRA) report for CFO David L. Lowrance?

Savara reported that CFO David L. Lowrance exercised multiple stock options, acquiring 366,747 shares of Common Stock on March 18, 2026. The filing also shows tax-withholding dispositions where shares were delivered to cover exercise costs and related tax liabilities.

How many Savara (SVRA) shares does the CFO hold after these Form 4 transactions?

After the reported transactions, CFO David L. Lowrance directly holds 536,032 shares of Savara common stock. This figure reflects both the option exercises that increased his position and the shares withheld to satisfy exercise price and tax obligations on March 18, 2026.

Were any of the Savara (SVRA) CFO’s Form 4 transactions open-market stock sales?

No open‑market sales are shown. The only dispositions reported are transactions coded F, which represent shares withheld by the issuer to pay the option exercise price or related tax liabilities. These are administrative, tax-related events rather than discretionary market sales.

What stock option grants did Savara (SVRA) CFO exercise in this Form 4?

The CFO exercised options to acquire shares at strike prices of $1.11, $1.23, $1.51, $1.59, $3.35 and $4.45. These options relate to grants that vest in sixteen equal quarterly installments, subject to continued service.

How many Savara (SVRA) shares were withheld for taxes in the CFO’s Form 4 filing?

The filing shows total tax-withholding dispositions of 116,760 shares of Common Stock across six transactions coded F. These shares were delivered to the issuer at prices including $5.04 per share to satisfy exercise price and associated tax obligations.

What do the vesting footnotes in the Savara (SVRA) Form 4 indicate about the CFO’s options?

The footnotes state each option grant vests in sixteen equal quarterly installments starting from specific grant dates, such as November 1, 2016 and December 12, 2024. Vesting is conditioned on the CFO’s continued service with Savara, reflecting typical long-term equity compensation.
Savara Inc

NASDAQ:SVRA

View SVRA Stock Overview

SVRA Rankings

SVRA Latest News

SVRA Latest SEC Filings

SVRA Stock Data

1.06B
186.84M
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN